Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S6 kinase-related protein (RSKR/SGK494) is a putative serine/threonine kinase based on sequence similarity to the S6 kinase family, but it is not well characterized in published research. It is distinct from the well-known S6 kinases (like RPS6KB1/S6K1 or RPS6KA1/RSK1) that regulate cell growth, translation, and mTOR signaling[1][4]. There is minimal to no functional data about RSKR/SGK494, and it is not listed as a drug target in major resources. Where referenced, the gene is usually annotated as an uncharacterized locus with possible serine/threonine kinase activity but without known substrates, biological pathways, or disease associations. As such, it should *not* be considered equivalent to S6K1 (RPS6KB1) or RSK (RPS6KA1-A4) kinases, which are distinct, well-validated protein families[1][4]. If you were seeking information on the canonical "ribosomal protein S6 kinase" or "ribosomal S6 kinase" families, please specify, as these refer to well-studied and therapeutically relevant kinases distinct from this poorly characterized entry[1][4].
None established
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S6 kinase-related protein (RSKR).